Title:
Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy
Document Type and Number:
Japanese Patent JP6286445
Kind Code:
B2
Abstract:
The present invention relates to the treatment and prevention of cancer. The present invention relates to vaccines comprising solubilized components of cancer cells or cancer-associated cells. Moreover, the present invention also relates to methods of producing vaccines from biological samples comprising cancer cells or cancer-associated cells and using said vaccines for the treatment or prevention of cancer in subjects. The present invention also relates to methods of producing vaccines, in particular, autologous vaccines. The present invention also relates to therapeutic uses of mesenchymal stem cells and to methods of treatment and or prevention that comprise administering mesenchymal stem cells to a subject. The present invention also relates to methods of enhancing the efficacy of vaccines and methods for the treatment and prevention of cancer, and to compositions and kits suitable for use in the methods.
Inventors:
Ross Arthur Davi
Christopher John Wire
Graham Vezi
Christopher John Wire
Graham Vezi
Application Number:
JP2015549902A
Publication Date:
February 28, 2018
Filing Date:
December 24, 2013
Export Citation:
Assignee:
Cell Ideas Peatiwai Limited
Northern Sydney Local Health District
Northern Sydney Local Health District
International Classes:
A61K39/00; A61K35/13; A61K38/16; A61P35/00
Domestic Patent References:
| JP62221636A |
Foreign References:
| US5030621 | ||||
| CN1887296B |
Other References:
Gao,J. et al.,GM-CSF-surface-modified B16.F10 melanoma cell vaccine.,Vaccine,2006年 6月19日,Vol.24, No.25,p.5265-8
Attorney, Agent or Firm:
Yasuhiko Murayama
Shinya Mitsuhiro
Tatsuhiko Abe
Shinya Mitsuhiro
Tatsuhiko Abe